Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Who Says Chivalry is Dead?—Sir2 Fights Against Aging in Mammals
17 June 2004. Sir Lancelot, for all his prowess protecting King Arthur’s court, couldn’t do one thing: prevent the death toll extracted by living high at the round table. Sir2 could have shown our legendary hero how to fight that battle gallantly. In today’s Sciencexpress, David Sinclair and colleagues at Harvard Medical School report that the mammalian protein SIRT1 promotes the survival of mammalian cells and suggest it may do so by preventing apoptosis. Like Sir2, SIRT1 is induced by caloric restriction (CR) and the actions of this protein open a door toward a better understanding of why CR delays the onset of numerous age-associated diseases, including Alzheimer’s disease, which has been linked to high caloric intake (see ARF related news story).

In yeast, caloric restriction leads to induction of the Sir2 histone deacetylase and subsequent gene silencing (see ARF related news story). To test if caloric restriction induces the Sir2 homolog SIRT1 in mammals, first author Haim Cohen and colleagues examined tissues extracted from year-old rats that had been fed either ad libitum, or a calorie-restricted diet (these animals ate about 40 percent less than their littermates). Cohen found that CR led to a greater abundance of SIRT1 in a variety of tissues including brain, liver, kidney and fat. In humans, CR may elicit similar changes because when Cohen grew human embryonic kidney cells (293T cells) in serum from CR rats, SIRT1 expression doubled.

So what does SIRT1 do in mammals? Work at Leonard Guarente’s lab at MIT has shown that SIRT1 can silence apoptotic forkhead transcription factors, such as Foxo3a (see Motta et al., 2004). But Sinclair and colleagues have found that SIRT1 can prevent apoptosis through an alternative pathway involving Bax, a protein which, when translocated to the outer mitochondrial membrane, triggers the release of cytochrome C, an apoptotic trigger. When Cohen examined 293T cells grown in serum from calorie-restricted rats, he found that they were less susceptible to Bax-mediated apoptosis.

Bax is normally sequestered in the cytosol by the protein Ku70. Acetylation of Ku70 releases Bax and pushes cells down the slippery apoptotic slope (see Cohen et al., 2004). Sinclair and colleagues wondered if the deacetylase activity of SIRT1 was the glue that holds Bax and Ku70 together. To test this, Cohen measured, in a test tube, deacetylation of Ku70 by SIRT1. Indeed, the authors found the SIRT1 could effectively remove acetyl groups from two Ku70 lysine residues that are essential for binding Bax. Similar results were obtained when Cohen measured acetylation of Ku70 in cells expressing normal or dominant-negative mutants of SIRT1.

All told, the experiments suggest that caloric restriction induces expression of the deacetylase, which then prevents acetylation of Ku70 and so retains Bax in the cytosol, where it does no damage. What component of rat CR-conditioned serum induces expression of SIRT1? While the scientists puzzle out this question, what’s a bon vivant to do? Very few people manage to stay on a caloric restriction for long, Mark Mattson being a famous exception from within the AD field. Maybe we can take one well-chosen leaf out of King Arthur’s book and live it up just a little. Recent findings from Sinclair’s group have shown the resveratrol, a polyphenol found in red wine, activates SIRT1. In yeast the polyphenol can increase life span by 70 percent (see Howitz et al., 2004). Other groups have sung resveratrol's praises as an antioxidant. A tankard, anyone?—Tom Fagan.

Reference:
Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA. Calorie restriction promotes cell survival by inducing the SIRT1 deacetylase. Sciencexpress 2004 June 17. Abstract

Q&A with David Sinclair

Q: At first blush, Ku70 brings to mind DNA repair. Could SIRT1's deacetylation of Ku70 exert its life-prolonging effect by helping the cell repair DNA breaks acquired with age?
A: It is very possible that Ku70 helps extend lifespan by controlling DNA repair and cell death. This would make a lot of sense. We are testing this possibility now.

Q: Korean scientists last year reported that caloric restriction increased Ku activity in some aging tissues but not others (Um et al., 2003), though they unfortunately did not report on brain. Did you see such differences?
A: I believe they tested DNA repair capacity, which we have not yet tested. We also don't know the effect of CR on Ku70's ability to prevent cell death in vivo yet. It's hard to test.

Q: Did you see any induction of chaperones with CR?
A: See deCabo et al., 2003. They showed that CR upregulates heat shock protein 70, a chaperone. This is also induced by CR serum, as we show in our paper.

Q: Caloric restriction by 40 percent makes for pretty austere living. For those whose flesh is too weak for that, does cutting 10 or 20 percent help, also?
A: It depends on where you start. If you are eating a lean diet already, then a 10% drop might have some benefit, but not as great as 30-40 percent. Basically, for this to work, your body has to be in a state of hunger for most of the time.

Q: Does this depend on body weight? How about people who eat a lot but stay thin?
A: This doesn't work. Just being thin is not severe enough to turn on the body's defenses.

Q: Do you have a specific research interest in neurodegeneration?
A: Not yet, but we will soon be looking at whether the SIRT1 enzyme plays a protective role in neurons and whether the SIRT1-activating molecules (STACs) that we discovered last year can slow neurodegeneration in mice.

 
Comments on News and Primary Papers
  Comment by:  Andrea LeBlanc
Submitted 17 June 2004  |  Permalink Posted 17 June 2004

The laboratory of David Sinclair shows an interesting feature of caloric restriction in this paper. Caloric restriction increases the levels of SIRT1, the mammalian counterpart of yeast Sir2, a nicotinamide adenosine dinucleotide-dependent histone deacetylase protein known to be involved in longevity mediated by caloric restriction. This effect can be mimicked in human embryonic kidney 293T cells by treating the cells with serum from calorie-restricted rats. This papers shows that SIRT1 deacetylates Ku70, allowing Ku70 to interact with the pro-apoptotic protein, Bax, and prevent Bax-mediated cell death. It is therefore suggested that calorie restriction extends lifespan through increased SIRT1 expression and promotion of survival of the organism’s irreplaceable cells.

Coupled with a recent paper in Molecular Cell (Cohen et al., 2004), this group shows a very compelling mechanism for the regulation of Bax function through the acetylation and deacetylation of Ku70, a DNA repair protein, originally discovered...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad